Probable adverse interaction between oral metoprolol and verapamil

Area of Science:

• Cardiology
• Pharmacology

Background:

• Beta-adrenergic blocking agents and verapamil are commonly prescribed for angina.
• The combination of these drugs is considered safe for managing angina.

Observation:

• A case study identified a patient experiencing Wenckebach type atrioventricular block.
• The patient was concurrently taking metoprolol (a beta-adrenergic blocking agent) and verapamil.

Findings:

• The concurrent administration of metoprolol and verapamil was associated with the development of Wenckebach type atrioventricular block.
• This adverse cardiac event highlights a potential drug interaction.

Implications:

• Clinicians should exercise caution when prescribing the combination of metoprolol and verapamil.
• Further investigation into the safety profile and potential risks of this drug combination is warranted.